CLINICAL_TRIALS
trial_result
· 2018-08-24
Clinical Trial Update: A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Summary
Phase 2 clinical trial update for lebekizumab in idiopathic pulmonary fibrosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2018-08-24